Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: ANDA 4.
| Dosage form | NDCs |
|---|---|
| solution | 2 |
| gel | 1 |
| lotion | 1 |
| Route | NDCs |
|---|---|
| topical | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| perfero pharma, inc. | 4 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Attero | calcipotriene and betamethasone dipropionate | solution, topical | 87143-100ANDA |
| Evesse | hydrocortisone butyrate | lotion, topical | 87143-420ANDA |
| Pellix | calcipotriene | solution, topical | 87143-300ANDA |
| Trilitas | TAZAROTENE | gel, topical | 87143-200ANDA |
Compare
Other companies listing tazarotene
- LETCO MEDICAL, LLC1 site · 224 NDC
- Mayne Pharma International Pty Ltd.1 site · 64 NDC
- PCAS Finland Oy1 site · 20 NDC
- CHONGQING HUAPONT SHENGCHEM PHARM. CO., LTD.0 sites · 10 NDC
Enquiry
Common questions
- Is Perfero Pharma, Inc. FDA approved?
- Perfero Pharma, Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Perfero Pharma, Inc. make?
- 4 products are listed under Perfero Pharma, Inc. in the openFDA NDC Directory, most often as solution; gel; lotion. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.